Skip to content
healthcare.dev

Ondansetron

NDC 51655-913, Ondansetron, tablet, orally disintegrating, from Northwind Health Company, LLC.

Product NDC
51655-913
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090469
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ONDANSETRON4 mg/1

Pharmacologic classes

Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]

Package NDCNDC-11Package
51655-913-205165509132020 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-20)
51655-913-535165509135310 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-53)
51655-913-545165509135415 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-913-54)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/db9a0d22-9339-4319-e053-2a95a90a9592

Use it

Look up 51655-913 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-913 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-913. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.